Topic

Insurance Approval

A collection of 6650 issues

Renewing Xenpozyme (Olipudase Alfa) Approval with Aetna CVS Health in Ohio: 2025 Requirements and Timeline

Answer Box: Renewing Xenpozyme Coverage in Ohio Start your Xenpozyme renewal 60-90 days before expiration to avoid treatment gaps. Aetna CVS Health requires updated clinical response data (spleen/liver volumes, platelet counts, chitotriosidase levels), continued ASMD diagnosis confirmation, and specialist attestation. First step today: Contact your metabolic specialist to schedule
6 min read

How to Get Acthar Gel Covered by Humana in Florida: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Acthar Gel Covered by Humana in Florida Humana requires prior authorization for Acthar Gel (repository corticotropin injection) in Florida for all Medicare Advantage, Medicaid, and Part D plans. Coverage is limited to FDA-labeled conditions like infantile spasms, MS exacerbations, and select rheumatologic disorders, typically requiring documented corticosteroid
6 min read

How to Get Bavencio (Avelumab) Covered by Humana in Georgia: Complete Approval Timeline and Appeals Guide

Answer Box: Fast Track to Bavencio Coverage Bavencio (avelumab) requires prior authorization from Humana in Georgia, typically taking 7-14 days for standard requests. Your oncologist must submit documentation proving FDA-approved indications (metastatic Merkel cell carcinoma or maintenance urothelial carcinoma post-platinum therapy), current staging scans, ECOG performance status 0-2, and medical
6 min read

How to Get Nucala (Mepolizumab) Covered by Cigna in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Nucala Covered by Cigna in Georgia Cigna requires prior authorization for Nucala (mepolizumab) with specific eosinophil count thresholds and step therapy documentation. For severe eosinophilic asthma, you'll need ≥300 cells/μL eosinophils within 6 weeks, failure of high-dose inhaled corticosteroids plus long-acting beta-agonist, and specialist
6 min read